Research Articles
Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach
Kemal Caglar Gogebakan, Elizabeth G. Berry, Alan C. Geller, Kemal Sonmez, Sancy A. Leachman and Ruth Etzioni
Kemal Caglar Gogebakan
1Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Elizabeth G. Berry
2Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
Alan C. Geller
3Division of Public Health Practice, Harvard School of Public Health, Boston, Massachusetts.
Kemal Sonmez
1Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Sancy A. Leachman
2Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
Ruth Etzioni
4Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
5Department of Statistics, University of Washington, Seattle, Washington.
DOI: 10.1158/1055-9965.EPI-20-0881 Published December 2020

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
December 2020
Volume 29, Issue 12
Volume 29, Issue 12
Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach
Kemal Caglar Gogebakan, Elizabeth G. Berry, Alan C. Geller, Kemal Sonmez, Sancy A. Leachman and Ruth Etzioni
Cancer Epidemiol Biomarkers Prev December 1 2020 (29) (12) 2599-2607; DOI: 10.1158/1055-9965.EPI-20-0881
Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach
Kemal Caglar Gogebakan, Elizabeth G. Berry, Alan C. Geller, Kemal Sonmez, Sancy A. Leachman and Ruth Etzioni
Cancer Epidemiol Biomarkers Prev December 1 2020 (29) (12) 2599-2607; DOI: 10.1158/1055-9965.EPI-20-0881
Jump to section
Advertisement